Corbus Pharmaceuticals
CRBP
22 hedge funds and large institutions have $9.21M invested in Corbus Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
12% more capital invested
Capital invested by funds: $8.26M → $9.21M (+$951K)
0% more funds holding
Funds holding: 22 → 22 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$197K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$124K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.3K |
| 4 |
YP
Yellowstone Partners
Idaho Falls,
Idaho
|
+$64.1K |
| 5 |
Renaissance Technologies
New York
|
+$48.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$214K |
| 2 |
EEG
E.E. Geduld
|
-$41K |
| 3 |
Millennium Management
New York
|
-$19K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$17K | -342 | Closed |
|
CRBP Hedge Fund Activity: Q1 2016 in Review
22 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q1 2016, worth a combined $9.21M — up 12% from $8.26M a quarter earlier.
Fund positioning in CRBP was balanced in Q1 2016: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was Raymond James Financial Services Advisors, adding an estimated $197K. The largest seller was Spark Investment Management, exiting entirely with an estimated $214K sold.
- 22 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $9.21M of Corbus Pharmaceuticals stock for Q1 2016, up 12% quarter-over-quarter.
- 4 funds opened new Corbus Pharmaceuticals positions in Q1 2016 and 4 closed out, a net change of 0 holders.
- The largest Corbus Pharmaceuticals buyer in Q1 2016 was Raymond James Financial Services Advisors, an estimated $197K added.
- The largest Corbus Pharmaceuticals seller in Q1 2016 was Spark Investment Management, an estimated $214K sold.
Based on aggregated 13F filings for Q1 2016.